
Priority Review from Denosumab for Bone Metastases, Orphan Drug Status from BiovaxID, Approval of Generic Enoxaparin
Author(s) -
AUTHOR_ID
Publication year - 2010
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000388584.07467.25
Subject(s) - denosumab , orphan drug , medicine , pharmacology , oncology , bioinformatics , osteoporosis , biology